Deerfield Beach, FL -- (SBWIRE) -- 05/30/2017 -- Latest industry research report on Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market. Increasing count of individuals suffering with cancer and cardiac ailments foster the demand of radiopharmaceuticals market. Factors expected to boost the growth of this market are rising awareness of radiopharmaceuticals coupled with increasing use of spect & pet scans results are the. However, very short half-life of radiopharmaceuticals along with cost of capital of scanners are the factors that are expected to hamper the growth of the market. The market faces stiff competition from conventional diagnostic procedures which is a key market challenge. Potential generation of radioisotopes in the pipeline along with cancer treatment based on alpha radioimmunotherapy and Cyclotron-Based Production are the factors that is expected to create abundant growth opportunities in this market.

Get Free Sample Report Of Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market @ http://www.marketresearchstore.com/report/asia-pacific-nuclear-medicineradiopharmaceuticals-stable-isotopes-market-71405#RequestSample

A Japanese reactor unable to suffice the domestic nuclear demand is a key threat faced by market players. Investments on discovery new radioisotopes and the use of radiopharmaceuticals and stable isotopes novel applications such as neurological applications are the winning imperatives adopted by market players to gain a stronghold of the market.

The report segments the market on the basis of isotope, application and country.

Asia-Pacific Radiopharmaceuticals Market By Isotope

Diagnostic Application
Spect
Cardiology
Lymphoma
Thyroid
Neurology
Others
Pet
Oncology
Cardiology
Neurology
Others

Asia-PacificRadiopharmaceuticals Market By Application/Indication

Diagnostic Application
Spect
Pet
Therapeutic Application
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Others

Do Inquiry To Buy Report Of Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market @ http://www.marketresearchstore.com/report/asia-pacific-nuclear-medicineradiopharmaceuticals-stable-isotopes-market-71405#InquiryForBuying

Asia-Pacific Radiopharmaceuticals Market By Country

Japan
China
India
South Korea
Malaysia
Indonesia
Australia
New Zealand
Others

Key Company Profile

Bracco Imaging S.P.A.
Cambridge Isotope Laboratories
Inc., Cardinal Health, Inc.
Covidien, Plc.
Eczacibasi-Monrol
Fujifilm Holdings Corporation
Iba Group, Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.